Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Innospec (IOSP) EBT (2016 - 2025)

Historic EBT for Innospec (IOSP) over the last 17 years, with Q3 2025 value amounting to $11.5 million.

  • Innospec's EBT fell 7433.04% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.2 million, marking a year-over-year decrease of 8191.43%. This contributed to the annual value of $90.2 million for FY2024, which is 4827.98% down from last year.
  • Per Innospec's latest filing, its EBT stood at $11.5 million for Q3 2025, which was down 7433.04% from $31.9 million recorded in Q2 2025.
  • Innospec's 5-year EBT high stood at $55.3 million for Q1 2024, and its period low was -$53.6 million during Q4 2024.
  • Moreover, its 5-year median value for EBT was $43.7 million (2024), whereas its average is $35.3 million.
  • In the last 5 years, Innospec's EBT soared by 17453.53% in 2021 and then crashed by 21832.23% in 2024.
  • Quarter analysis of 5 years shows Innospec's EBT stood at $32.7 million in 2021, then skyrocketed by 38.23% to $45.2 million in 2022, then increased by 0.22% to $45.3 million in 2023, then plummeted by 218.32% to -$53.6 million in 2024, then soared by 121.46% to $11.5 million in 2025.
  • Its last three reported values are $11.5 million in Q3 2025, $31.9 million for Q2 2025, and $44.4 million during Q1 2025.